Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06329492 · ClinicalTrials.gov registry record · Phase 1
Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis
A Phase 1 study of Osteoarthritis and Knee Osteoarthritis, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06329492 is a Phase 1 study of Osteoarthritis and Knee Osteoarthritis that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 818-participant average among 135 other Osteoarthritis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06329492, a Phase 1 study of Osteoarthritis and Knee Osteoarthritis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effectiveness and safety of autologous alpha-2 macroglobulin rich plasma (A2MRP) injections in the treatment of knee osteoarthritis (OA).
Conditions Studied
Interventions
- BIOLOGICAL Autologous Alpha-2 Macroglobulin Rich Plasma (A2MRP)
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-01-09 |
| Est. Completion | 2026-02-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06329492
The ClinicalTrials.gov registry entry for NCT06329492 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 818-participant average among 135 other Osteoarthritis trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Autologous Alpha-2 Macroglobulin Rich Plasma (A2MRP) is the first listed.
NCT06329492 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06329492 about?
NCT06329492 is a clinical study titled "Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis". The purpose of this study is to determine the effectiveness and safety of autologous alpha-2 macroglobulin rich plasma (A2MRP) injections in the treatment of knee osteoarthritis (OA).
What is the current status of trial NCT06329492?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2024-01-09. Estimated completion is 2026-02-06.
What conditions does trial NCT06329492 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee Osteoarthritis, OA.
What interventions are being tested in trial NCT06329492?
The interventions under investigation include: Autologous Alpha-2 Macroglobulin Rich Plasma (A2MRP) (BIOLOGICAL).
Who is sponsoring clinical trial NCT06329492?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06329492 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustained Acoustic Medicine for Osteoarthritis Pain
RECRUITING · Phase 1
-
A Study With GLPG1972 in Osteoarthritis Subjects
COMPLETED · Phase 1
-
Translating Metabolic Responses to Mechanical Insult Into Early Interventions to Prevent PTOA
COMPLETED · Phase 1
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.